BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 12016492)

  • 21. Advanced botulinum toxin techniques against wrinkles in the upper face.
    Salti G; Ghersetich I
    Clin Dermatol; 2008; 26(2):182-91. PubMed ID: 18472059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.
    Fagien S; Cox SE; Finn JC; Werschler WP; Kowalski JW
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines.
    Lizarralde M; GutiƩrrez SH; Venegas A
    Dermatol Surg; 2007 Nov; 33(11):1328-33; discussion 1333. PubMed ID: 17958584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of botulinum toxin type A on full-face intense pulsed light treatment: a randomized, double-blind, split-face study.
    Khoury JG; Saluja R; Goldman MP
    Dermatol Surg; 2008 Aug; 34(8):1062-9. PubMed ID: 18462423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin in the lower one third of the face.
    Atamoros FP
    Clin Dermatol; 2003; 21(6):505-12. PubMed ID: 14759584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A.
    Chang SP; Tsai HH; Chen WY; Lee WR; Chen PL; Tsai TH
    Int J Dermatol; 2008 Dec; 47(12):1287-94. PubMed ID: 19126019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin (botox) chemodenervation for facial rejuvenation.
    Carruthers J; Carruthers A
    Facial Plast Surg Clin North Am; 2001 May; 9(2):197-204, vii. PubMed ID: 11457686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
    Grosse J; Kramer G; Jakse G
    BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin. The Newport Beach experience.
    Fulton JE
    Dermatol Surg; 1998 Nov; 24(11):1219-24. PubMed ID: 9834742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Injection techniques for the upper part of the face: forehead and periocular region].
    Gassia V; Michaud T
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S104-10. PubMed ID: 19576475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indications and limitations for the use of botulinum toxin for the treatment of facial wrinkles.
    Sarrabayrouse MA
    Aesthetic Plast Surg; 2002; 26(4):233-8. PubMed ID: 12397444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin A for the treatment of lateral periorbital rhytids.
    Kim DW; Cundiff J; Toriumi DM
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):445-51. PubMed ID: 15062248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the patient for cosmetic Botox injections.
    Dayan SH; Bassichis BA
    Facial Plast Surg Clin North Am; 2003 Aug; 11(3):349-58. PubMed ID: 15062263
    [No Abstract]   [Full Text] [Related]  

  • 35. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botox in men.
    Flynn TC
    Dermatol Ther; 2007; 20(6):407-13. PubMed ID: 18093014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cohort study on patient response to botulinum toxin cosmetic therapy.
    Lee H; Saladi RN; Fox JL
    J Cosmet Dermatol; 2008 Mar; 7(1):39-42. PubMed ID: 18254810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction.
    Sepehr A; Chauhan N; Alexander AJ; Adamson PA
    Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary and adjunctive uses of botulinum toxin type A in the periorbital region.
    Balikian RV; Zimbler MS
    Facial Plast Surg Clin North Am; 2005 Nov; 13(4):583-90, vii. PubMed ID: 16253845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of Botox to treat glabellar rhytids.
    Bassichis BA; Thomas JR
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):453-6. PubMed ID: 15062249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.